Overview


According to FutureWise analysis the market for Pet Diabetes Care Devices in 2023 is US$ 1.87 billion, and is expected to reach US$ 3.57 billion by 2031 at a CAGR of 8.50%.

The disease occurs when the beta cells in the endocrine pancreas stop producing insulin or are unable to produce enough insulin for the body's requirements. This disease can also affect animals like dogs and humans. This condition can be treated and will not affect the animal's quality of life or reduce its life expectancy. The condition can cause cataracts, weakness in the legs (neuropathy), malnutrition, and ketoacidosis. It can also lead to death. While diabetes is most common in older dogs and middle-aged people, there are also cases of juvenile diabetes. A typical canine diabetic is middle-aged, female, and obese at diagnosis. The market's growth is driven by the increasing number of diabetic pets, the adoption of overweight pets, and the increase in the number of adopted pets. In recent years, the adoption rate of animals has been increasing dramatically, particularly cats and dogs. They are thought to improve mental and physical health. Due to a variety of factors, including economic conditions, industrialized countries are the most dominant in companion animal ownership. It is easy to blame pet owners for not monitoring their pet's health enough with a pet glucose monitor. This will help prevent them from developing diabetes-related complications. Insulin therapy is vital for diabetic cats and dogs. There are many forms of insulin that have been proven to be effective. Insulin reduces blood glucose by increasing peripheral glucose intake and decreasing liver glucose synthesis. The glucometer for pets helps monitor and prevent amyloid polypeptide deposits from developing in cats. Insulin is, therefore, the best treatment for diabetic dogs and cats. Caninsulin and Vetsulin are licensed to use Pig Lente insulin in dogs and cats. It has a moderate action time. ProZinc (Boehringer-Ingelheim) can be used for diabetic dogs and cats. Obesity is a leading problem in pets today. It can be attributed to the unhealthy diets of both humans and pets. An animal glucose monitor is becoming an essential tool for pet owners. It helps to maintain their health and check their blood sugar levels. The market for pet diabetes care devices is growing rapidly. Insufficient insulin synthesis leads to insufficient glucose transfer. This can lead to dysfunctional cell function and tissue energy deprivation. The liver begins to metabolize extra sugar stored in fat cells, muscles, and liver cells. An increasing number of dogs and cats are being diagnosed with it. Diabetes is a chronic condition that affects older dogs most often, but it can also occur in younger animals. A dog with diabetes needs to be cared for throughout its life. This includes a healthy exercise program, proper nutrition, and a painless glucose monitoring device for dogs. Some pets, particularly cats, are more susceptible to diabetes than humans. However, obesity can increase the likelihood of developing diabetes in pets. Pet owners and key players in the pet diabetic care market are making greater efforts to improve their treatment. Continuous glucose monitors for cats' care do not have any adverse effects on a pet’s quality of life.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Pet Diabetes care Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share, and regional proliferation of this business. Moreover, the report offers insights into the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Pet Diabetes Care Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a special growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  •  Allison Medical
  •  Apotex Inc
  •  Becton, Dickinson, and Company
  •  Boehringer Ingelheim Vetmedica Inc.
  •  Henry Schein Animal Health
  •  MED TRUST
  •  Merck & Co., Inc.
  •  UltiMed Inc.
  •  Zoetis Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Animal Type

  •  Cats
  •  Dogs
  •  Horses

By Device

  •  Insulin Delivery Devices
  •  Insulin Delivery Pen
  •  Insulin Syringes
  •  Glucose Monitoring Devices

By End User

  •  Veterinary clinics
  •  Home Care Settings
  •  Veterinary Hospitals

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

  •  Tier 1 players- established companies in the market with a significant market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants

  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data points affecting the market growth

  •  To provide with an exhaustive analysis of the Pet Diabetes Care Devices Market By Animal Type, By Device, By End User, and By Region.
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and the Middle East, and Africa.
  •  To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers, and expansions

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered is free of charge with the purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content with: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Pet Diabetes care Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Pet Diabetes care Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Pet Diabetes Care Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Pet Diabetes Care Devices Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cats
        2. Dogs
        3. Horses

  • 8.   Pet Diabetes Care Devices Market, By Device Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Insulin Delivery Devices
        2. Insulin Delivery Pen
        3. Insulin Syringes
        4. Glucose Monitoring Devices

  • 9.   Pet Diabetes Care Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Veterinary clinics
        2. Home Care Settings
        3. Veterinary Hospitals

  • 10.   North America Pet Diabetes Care Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Pet Diabetes Care Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Pet Diabetes Care Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Pet Diabetes Care Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Pet Diabetes Care Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue, and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered, and Financial Layouts)
    •   1. Allison Medical
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Apotex Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Becton, Dickinson and Company
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Boehringer Ingelheim Vetmedica Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Henry Schein Animal Health
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. MED TRUST,
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. MerckCo., Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. UltiMed Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Zoetis Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 17.   Pre and Post-COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients